|
|
Q1 |
Q3 |
Q5 |
p-value |
|
N (%) |
4107 |
4731 |
3111 |
|
Age
|
18-39
40-49
50-59
60-69
70-79
80+
|
48 (1.2)
255 (6.2)
1176 (28.7)
1507 (36.7)
831 (20.2)
290 (7.1)
|
105 (2.2)
371 (7.8)
1261 (26.7)
1624 (34.3)
919 (19.4)
451 (9.5)
|
82 (2.6)
257 (8.2)
835 (26.8)
1065 (34.2)
556 (18.9)
316 (10.2)
|
<0.001
|
Charlson Score
|
0
1-2
3+
No Admissionb
|
1102 (26.8)
886 (21.6)
176 (4.3)
1943 (47.3)
|
1093 (23.1)
1112 (23.5)
279 (5.9)
2247 (47.5)
|
629 (20.2)
740 (23.8)
204 (6.6)
1538 (49.4)
|
<0.001
|
Severe Obesity |
BMI>40 |
718 (17.5) |
836 (17.7) |
558 (17.9) |
0.80 |
Income Quintile
|
1
2
3
4
5
|
30 (0.7)
210 (5.1)
587 (14.3)
1172 (28.5)
2107 (51.3)
|
539 (11.4)
1287 (27.2)
1452 (30.7)
959 (20.3)
493 (10.4)
|
1986 (64.0)
771 (24.9)
207 (6.7)
86 (2.8)
53 (1.7)
|
<0.001
|
Rural Residence |
|
877 (21.4) |
507 (10.7) |
NR |
<0.001 |
Histology
|
Endometrioid
Serous
Mixed
Carcinosarcoma
Clear Cell
Undifferentiated
Other/Missing
|
3095 (75.4)
153 (3.7)
60 (1.5)
248 (6.0)
164 (4.0)
54 (1.3)
333 (8.1)
|
3409 (72.1)
194 (4.1)
67 (1.4)
355 (7.5)
180 (3.8)
60 (1.3)
466 (9.9)
|
2199 (70.7)
305 (9.8)
241 (7.8)
147 (4.7)
43 (1.4)
58 (1.9)
118 (3.8)
|
<0.001
|
Stage
|
1
2
3
4
Unknown
|
2281 (55.5)
264 (6.4)
298 (7.3)
180 (4.4)
1084 (26.4)
|
2419 (51.1)
325 (6.9)
364 (7.7)
174 (3.7)
1449 (30.6)
|
1506 (48.4)
195 (6.3)
289 (9.3)
148 (4.8)
973 (31.3)
|
<0.001
|
Prior Cancerc |
|
224 (5.5) |
219 (4.6) |
151
(4.9) |
0.42 |
No Surgery Performed |
|
299 (7.3) |
435 (9.2) |
332 (10.7) |
<0.001 |
Surgery >180d after diagnosis |
|
81 (2.0) |
113
(2.4) |
84 (2.7) |
|
MISd |
|
1374 (36.1) |
1629 (37.9) |
1097
(39.5) |
0.006 |
Surgeon Specialty
|
Gynecologic Oncologist
General Gynecologist
Other/Unknown
|
1574 (41.3)
1971 (51.8)
273 (6.9)
|
1711 (39.8)
2258 (52.6)
327 (7.7)
|
1196 (43.0)
1370 (49.3)
213 (7.6)
|
<0.001
|
Hospital Type for Surgery
|
Community
Teaching
Other/Unknown
|
1912 (50.2)
1556 (40.9)
340 (9.0)
|
2322 (54.1)
1562 (36.4)
412 (9.6)
|
1261 (45.4)
1204 (43.3)
314 (11.3)
|
<0.001
|